The lowered price target from $19 to $17 by RBC Capital analyst Sean Dodge indicates a potential negative short-term impact on NextGen Healthcare's stock price. The maintained Sector Perform rating suggests that the stock is expected to perform in line with the market, but the reduced price target may cause investors to reevaluate their positions.